Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Embla Medical – Presentation of Q4 2024

By HC Andersen Capital
05.02.2025, 11.00
Embla Medical

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Embla Medical will release its Q4 2024 interim report on 5 February 2025. The same day at 11.00, the company’s management will present the results and answer questions in an online live event. Besides the financial results, you can get an update on the recent business and regulatory developments.

For the first nine months of 2024, Embla Medical realized an organic growth of 7% (10% including acquisitions) and an EBITDA margin of 20%. The first nine months of 2024 were in line with the full-year guidance that the company reiterated in connection with the Q3 2024 report. For the full year 2024, Embla Medical expects 6-8% organic growth and an EBITDA margin before special of approx. 20%.

In connection with the Q4 report, we expect that the focus will be on the 2025 guidance. 2025 will be the first full year with the effects of the positive changes to the US reimbursement and the second year in Embla Medical’s Growth’27 strategy period with the ambition of annual revenue growth of 7-10% both organically and through acquisitions, with gradually increasing EBITDA margins.

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics & Neuro Orthotics, Bracing & Supports, and Patient Care.

Dislcaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 09.22, 9 January 2025.

Aktier i Vælten – Byggesektoren: Én af de bedst performende sektorer i år
23.05.2025, 15.24 Rockwool
SP Group – Presentation of the quarterly report for Q1 2025
23.05.2025, 15.00 SP Group
Endomines as an Investment | Investor Day May 19, 2025
23.05.2025, 13.00 Endomines Finland
AKTIER MED FRIIS - UGE 21 2025
23.05.2025, 12.00
SP Group – Præsentation af regnskabet for 1. kvartal 2025
23.05.2025, 10.00 SP Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.